Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy
2012 · Journal of Thoracic Oncology · 351 citations
https://doi.org/10.1097/jto.0b013e318247504a
A
Arlene M. Correa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
321
Papers
13.7K
Citations
68
h-index
180
i10-index
Arlene M. Correa is an academic researcher from Secretaría de Salud de Bogotá. The author has contributed to research in topics: Esophageal Cancer Research and Treatment & Gastric Cancer Management and Outcomes & Esophageal and GI Pathology. The author has an h-index of 68, co-authored 273 publications.
ORCID: 0009-0001-8495-6602Papers by this author
worksPosterior Intercostal Nerve Block With Liposomal Bupivacaine: An Alternative to Thoracic Epidural Analgesia
2015 · The Annals of Thoracic Surgery · 158 citations
https://doi.org/10.1016/j.athoracsur.2015.02.074
Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2-<b> <i>neu</i> </b> Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer
2004 · Clinical Cancer Research · 136 citations
https://doi.org/10.1158/1078-0432.ccr-0373-3
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy
2020 · Clinical Lung Cancer · 112 citations
https://doi.org/10.1016/j.cllc.2019.11.003
Tumor Cavitation in Stage I Non–Small Cell Lung Cancer: Epidermal Growth Factor Receptor Expression and Prediction of Poor Outcome
2005 · Radiology · 102 citations
https://doi.org/10.1148/radiol.2371041650
Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy
2021 · Journal of Thoracic Oncology · 46 citations
https://doi.org/10.1016/j.jtho.2021.03.029
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat